FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1987065859> ?p ?o ?g. }

• W1987065859 endingPage "4122" @default.
• W1987065859 startingPage "4117" @default.
• W1987065859 abstract "Abstract Purpose: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is known to protect cells against apoptosis. We raised the hypothesis that elevated tumor tissue levels and thereby plasma levels of TIMP-1 would predict resistance to apoptosis-inducing chemotherapy. Experimental Design: Ninety patients with metastatic colorectal cancer were included in the study. Plasma TIMP-1 and serum carcinoembryonic antigen (CEA) were measured in samples obtained before the first cycle of chemotherapy. Results: Analysis of best objective response (complete or partial response versus stable or progressive disease) showed that patients with low plasma TIMP-1 had higher probability of obtaining an objective response [odds ratio (OR), 3.5; 95% confidence interval (95% CI), 1.4-8.5, P = 0.007]. CEA treated as a continuous variable was also a statistically significant predictor of no response (OR, 1.3; 95% CI, 1.0-1.7, P = 0.02, area under the curve 0.66) but much less so. Plasma TIMP-1 was the only significant covariate in a multivariable analysis of best objective response (OR, 3.6; 95% CI, 1.4-9.5; P = 0.001). Plasma TIMP-1 scored as a continuous variable on the log scale (loge) was significantly associated with overall survival [OS; hazard ratio (HR), 3.8; 95% CI, 2.4-5.9; P &lt; 0.0001] and with time to progression (TTP; HR, 1.5; 95% CI, 1.0-2.3; P = 0.048). Multivariable analysis showed that plasma TIMP-1 was significant for OS when including routine clinical baseline covariates (HR, 3.5; 95% CI, 2.1-5.8; P &lt; 0.0001). A multivariable analysis including TTP instead of OS showed that only plasma TIMP-1 was retained in the model (HR, 1.5). CEA was not significantly associated with TTP or OS when TIMP-1 was included in the model. Conclusion: This study shows that plasma TIMP-1 levels are significantly and independently associated with objective response, TTP, and OS in patients with metastatic colorectal cancer receiving combination chemotherapy." @default.
• W1987065859 created "2016-06-24" @default.
• W1987065859 creator A5013720146 @default.
• W1987065859 creator A5018043069 @default.
• W1987065859 creator A5044651904 @default.
• W1987065859 creator A5061540737 @default.
• W1987065859 creator A5063977962 @default.
• W1987065859 creator A5067589745 @default.
• W1987065859 creator A5086607557 @default.
• W1987065859 date "2007-07-15" @default.
• W1987065859 modified "2023-10-01" @default.
• W1987065859 title "TIMP-1 Is Significantly Associated with Objective Response and Survival in Metastatic Colorectal Cancer Patients Receiving Combination of Irinotecan, 5-Fluorouracil, and Folinic Acid" @default.
• W1987065859 cites W1691844459 @default.
• W1987065859 cites W1965876379 @default.
• W1987065859 cites W1989963027 @default.
• W1987065859 cites W1991803238 @default.
• W1987065859 cites W1993424211 @default.
• W1987065859 cites W2013082155 @default.
• W1987065859 cites W2014403304 @default.
• W1987065859 cites W2026996665 @default.
• W1987065859 cites W2034884841 @default.
• W1987065859 cites W2035548685 @default.
• W1987065859 cites W2056901325 @default.
• W1987065859 cites W2102303842 @default.
• W1987065859 cites W2121061548 @default.
• W1987065859 cites W2128601920 @default.
• W1987065859 cites W2139248078 @default.
• W1987065859 cites W2152726822 @default.
• W1987065859 cites W2159365419 @default.
• W1987065859 cites W2164407945 @default.
• W1987065859 cites W2165898752 @default.
• W1987065859 doi "https://doi.org/10.1158/1078-0432.ccr-07-0186" @default.
• W1987065859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17634538" @default.
• W1987065859 hasPublicationYear "2007" @default.
• W1987065859 type Work @default.
• W1987065859 sameAs 1987065859 @default.
• W1987065859 citedByCount "68" @default.
• W1987065859 countsByYear W19870658592012 @default.
• W1987065859 countsByYear W19870658592013 @default.
• W1987065859 countsByYear W19870658592014 @default.
• W1987065859 countsByYear W19870658592015 @default.
• W1987065859 countsByYear W19870658592016 @default.
• W1987065859 countsByYear W19870658592017 @default.
• W1987065859 countsByYear W19870658592018 @default.
• W1987065859 countsByYear W19870658592019 @default.
• W1987065859 countsByYear W19870658592020 @default.
• W1987065859 countsByYear W19870658592021 @default.
• W1987065859 countsByYear W19870658592022 @default.
• W1987065859 countsByYear W19870658592023 @default.
• W1987065859 crossrefType "journal-article" @default.
• W1987065859 hasAuthorship W1987065859A5013720146 @default.
• W1987065859 hasAuthorship W1987065859A5018043069 @default.
• W1987065859 hasAuthorship W1987065859A5044651904 @default.
• W1987065859 hasAuthorship W1987065859A5061540737 @default.
• W1987065859 hasAuthorship W1987065859A5063977962 @default.
• W1987065859 hasAuthorship W1987065859A5067589745 @default.
• W1987065859 hasAuthorship W1987065859A5086607557 @default.
• W1987065859 hasBestOaLocation W19870658591 @default.
• W1987065859 hasConcept C121608353 @default.
• W1987065859 hasConcept C126322002 @default.
• W1987065859 hasConcept C143998085 @default.
• W1987065859 hasConcept C156957248 @default.
• W1987065859 hasConcept C207103383 @default.
• W1987065859 hasConcept C2776694085 @default.
• W1987065859 hasConcept C2777387746 @default.
• W1987065859 hasConcept C2779804826 @default.
• W1987065859 hasConcept C2780259306 @default.
• W1987065859 hasConcept C2780456651 @default.
• W1987065859 hasConcept C44249647 @default.
• W1987065859 hasConcept C526805850 @default.
• W1987065859 hasConcept C71924100 @default.
• W1987065859 hasConcept C90924648 @default.
• W1987065859 hasConceptScore W1987065859C121608353 @default.
• W1987065859 hasConceptScore W1987065859C126322002 @default.
• W1987065859 hasConceptScore W1987065859C143998085 @default.
• W1987065859 hasConceptScore W1987065859C156957248 @default.
• W1987065859 hasConceptScore W1987065859C207103383 @default.
• W1987065859 hasConceptScore W1987065859C2776694085 @default.
• W1987065859 hasConceptScore W1987065859C2777387746 @default.
• W1987065859 hasConceptScore W1987065859C2779804826 @default.
• W1987065859 hasConceptScore W1987065859C2780259306 @default.
• W1987065859 hasConceptScore W1987065859C2780456651 @default.
• W1987065859 hasConceptScore W1987065859C44249647 @default.
• W1987065859 hasConceptScore W1987065859C526805850 @default.
• W1987065859 hasConceptScore W1987065859C71924100 @default.
• W1987065859 hasConceptScore W1987065859C90924648 @default.
• W1987065859 hasIssue "14" @default.
• W1987065859 hasLocation W19870658591 @default.
• W1987065859 hasLocation W19870658592 @default.
• W1987065859 hasLocation W19870658593 @default.
• W1987065859 hasOpenAccess W1987065859 @default.
• W1987065859 hasPrimaryLocation W19870658591 @default.
• W1987065859 hasRelatedWork W1565477874 @default.
• W1987065859 hasRelatedWork W1565506651 @default.
• W1987065859 hasRelatedWork W1970193197 @default.
• W1987065859 hasRelatedWork W1979613547 @default.
• W1987065859 hasRelatedWork W2010991676 @default.
• W1987065859 hasRelatedWork W2136055188 @default.

• next